# Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

> **NCT02240381** · NA · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 22 (actual)

## Conditions studied

- Diabetes Mellitus
- Malignant Neoplasm

## Interventions

- **PROCEDURE:** assessment of therapy complications
- **PROCEDURE:** assessment of therapy complications
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02240381
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11-20
- **Primary completion:** 2019-01-08
- **Final completion:** 2019-01-08
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Funding expired
- **Last updated:** 2019-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02240381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02240381, "Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02240381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*